Bioequivalence/Food Effect - Saxa/Dapa Dual Fixed Dose Combination (FDC)

Clinical trial NCT02060201 · COMPLETED

Trial details

NCT number: NCT02060201
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2014-02-01
Primary completion: 2014-05-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.